Personalized medicine refers to a treatment approach in which a therapy is optimally tailored to the individual characteristics of the patient. In oncology, most cancers can now be treated effectively with standard therapies according to the so-called guidelines, but it is now also known that not all cancers are the same. Rather, complex and individual molecular characteristics of cancer cells are responsible, for example, for tumors growing at different rates or responding differently to therapies. Patients with advanced or rare cancers, in particular, may therefore find that guideline-based treatments are unsuccessful or lacking. In these cases, a detailed examination of the tumour using modern molecular and imaging analysis methods can help to identify the individual characteristics of the tumour and the person affected and to find a targeted, personalized therapy that is tailored to the patient's disease.

Your attending physician is best placed to assess whether the use of personalized medicine is sensible and helpful in your individual case. Ask your treating oncologist to check the option of a molecular analysis via a ZPM. Your oncologist will then register you with the ZPM. You do not have to travel far for this diagnosis, as only data/physician's letters need to be sent to the ZPM. You can usually continue your therapy at your local Clinical Department or oncology specialist practice. If you or your physician have any further questions, you can also contact mtb-ccc@mh-hannover.de directly.

If you have any questions about cancer and treatment or would like a second opinion, you are also welcome to contact our Cancer Center.

Oncology Center at the CCC Hannover
Onkologisches.Zentrum@mh-hannover.de
☎️ 0511 532-3468

• Access to optimal and individualized care for patients with rare or advanced cancers in Lower Saxony for whom standard treatment options have been exhausted
• Performance and evaluation of molecular diagnostics according to established standards
• Registration and discussion of patients in the Molecular Tumor Board (MTB) (see "Prerequisites for registration")
• Individualized treatment recommendations from experts from various disciplines based on the diagnostic findings
• Referral to suitable clinical trials if possible and by arrangement